✨
Yapay Zeka Hızlı Bakış & Çıkarımlar
AI Insight⚡ TL;DR(1 Cümlede Hızlı Çıkarım)
The measured systemic lupus activity was declined from 19.0 to 4.38 (p
📌 3 Maddede Bu Makale
🎯
Amaç & Hipotez:High dose intravenous immunoglobulins (IVIG) have become an important treatment modality for some immune mediated diseases.
📊
Temel Bulgular & Veri:Eight patients with active renal involvement disease (all of them female, mean age; 25.8 ± 8.1, mean disease duration; 30.5 ± 16.1 months) were given 400 mg/kg/day 4. generation IVIG preparation (Octagam.
💡
Sonuç & Katkı:The measured systemic lupus activity was declined from 19.0 to 4.38 (p
🔬Tür:Araştırma Makalesi
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Alan Parametreleri
Abstract
High dose intravenous immunoglobulins (IVIG) have become an important treatment modality for some immune mediated diseases. We investigated the effect of high dose IVIG in systemic lupus erythematosus (SLE). Eight patients with active renal involvement disease (all of them female, mean age; 25.8 ± 8.1, mean disease duration; 30.5 ± 16.1 months) were given 400 mg/kg/day 4. generation IVIG preparation (Octagam. Octapharma, Pharmazeutika Wien, Austria) during the days 1 to 5 and 21 to 25. Overall disease activity was measured by the SLAM score. The measured systemic lupus activity was declined from 19.0 to 4.38 (p
🔖
Bu Makaleye Atıf Yap
KINIKLI, G., KESKİN, G., TURGAY, M., TOKGÖZ, G., DUMAN, M. (2022). High dose intravenous immunoglobulin (IVIG) treatment in patients with lupus nephritis. Journal of Ankara Medical School, Cilt: 20 - Sayı: 2, 95–98. https://ajindex.com/articles/560101